Please login to the form below

Not currently logged in
Email:
Password:

metformin

This page shows the latest metformin news and features for those working in and with pharma, biotech and healthcare.

J&J says real-world data finds no amputation risk for Invokana

J&J says real-world data finds no amputation risk for Invokana

Invokana and line extension such as the Invokamet combination with metformin saw sales slump by a fifth to $1.1bn in 2017 as the impact of the boxed warning took hold,

Latest news

More from news
Approximately 6 fully matching, plus 182 partially matching documents found.

Latest Intelligence

  • Market dynamics, marketing and analytics Market dynamics, marketing and analytics

    Complements are products that are often used together. Sometimes this distinction becomes blurred, as with metformin, which is a treatment for type II diabetes in its own right and also used ... market. The large product beside Januvia is metformin that,

  • Interview: Christopher Boulton, AstraZeneca Interview: Christopher Boulton, AstraZeneca

    sitagliptin) and Bristol-Myers Squibb (BMS), the original marketers of diabetes standard metformin under the brand name Glucophage. ... We probably have the broadest offering of products in diabetes in that middle space from when people start in

  • Pharma deals during November 2013 Pharma deals during November 2013

    The all-cash transaction is expected to close in Q1 2014. The combined company will market 22 products, including Xifaxan (rifaximin; 2012 sales of $514.5m) and Santarus' therapy Glumetza (metformin)

  • Rise of generic medicines in Portugal Rise of generic medicines in Portugal

    Generics bestsellers in volume. Simvastatin. Alprazolam. Oneprazol. Ibuprofen. Paracetamol. Metformin. Nimesulide.

  • The rise of chronic disease in BRIC markets The rise of chronic disease in BRIC markets

    The most commonly used oral/ non-insulin injectables are Metformin (37 per cent), Glucobay (21 per cent), Glipizide (15 per cent) and Tangshiping (11 per cent). ... In March 2013, Merck Serono and Bristol-Myers Squibb struck a deal to co-promote a

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics